Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Pneumagen Targeting The Human Glycome To Block Viral Entry

COVID-19 Among Potential Uses

29 Dec 2020

• By John Davis

Related Content

Coronavirus Update: UK Trials Six Candidates

29 Apr 2020

Related Companies

Pneumagen Ltd

Additional Topics

Financing Research & Development Coronavirus COVID-19 StartUps and SMEs Emerging Company Profile Infectious Diseases BioPharmaceutical

More from Emerging Company Profiles

More from Start-Ups & SMEs

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.